Optimizing Access to Heart Failure Care in Canada During the COVID-19 Pandemic

Sean A Virani1, Brian Clarke2, Anique Ducharme3

  • 1University of British Columbia, Vancouver, British Columbia, Canada.

Insights

The COVID-19 pandemic disrupted traditional heart failure (HF) care in Canada. New strategies and technologies are needed to optimize guideline-directed care and prevent hospitalizations for HF patients.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • The COVID-19 pandemic has significantly impacted traditional multidisciplinary, clinic-based heart failure (HF) care models in Canada.
  • Physical distancing and workforce reductions pose challenges to maintaining optimal HF patient health status and guideline-directed care.

Purpose of the Study:

  • To provide perspectives from Canadian Heart Failure Society leadership on optimizing HF care during the COVID-19 pandemic.
  • To address the need for innovative strategies to mitigate risks of decompensation and hospitalization in HF patients.
  • To explore how the pandemic necessitates the adoption of novel technologies and revised care models for HF management.

Main Methods:

  • This perspective piece synthesizes expert opinions from leadership within the Canadian Heart Failure Society.
  • It focuses on identifying challenges and proposing adaptive strategies for HF care delivery.
  • The approach involves re-evaluating existing care models, processes, and workflows in light of pandemic-induced constraints.

Main Results:

  • The pandemic presents a critical opportunity to innovate HF care delivery in Canada.
  • Adoption of novel technologies and revised care models are essential for maintaining patient health.
  • New strategies are required to reduce the risk of heart failure decompensation and hospitalizations.

Conclusions:

  • The COVID-19 crisis serves as a catalyst for transforming heart failure care in Canada.
  • Innovative approaches, including technology integration, are crucial for supporting vulnerable HF populations.
  • The insights gained can inform the future of heart failure management and delivery models.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
154
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
175
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
342
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
161